PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Titan Medical Inc.

USPTO PatentsView assignee record — 119 granted patents across 22 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Explore the portfolio See the ranking
119
Total patents granted
22
CPC technology areas
19.2
Avg claims per patent
+296%
5-year filing velocity

The verdict

Titan holds 119 US patents across 22 technology areas — rank #3,166 of 50,000 tracked assignees.

#3,166
of 50,000 US assignees by volume
Top 12%
by Innovation Score (51.0/100)
19.2
avg claims per patent
+296%
filing velocity, last 5 yrs

Portfolio overview

Titan Medical Inc. has been granted 119 US utility patents between 2015 and 2025, placing Titan Medical Inc. at rank #3,166 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.2 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Titan Medical Inc. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 51.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 95 grants, compared with 24 in the 2015–2019 window — a +296% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Titan Medical Inc.'s 19.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 22 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Titan Medical Inc. against peers pursuing similar technology classes.

How does Titan compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Titan holds 119 patents — placing it at rank #3,166 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Titan's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

-100102030 20152016201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Titan Medical Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 2.5%
2016 1 0.8%
2017 4 3.4%
2018 4 3.4%
2019 12 10.1%
2020 16 13.4%
2021 26 21.8%
2022 17 14.3%
2023 23 19.3%
2024 12 10.1%
2025 1 0.8%

Which technologies does Titan Medical Inc. patent most?

Top 15 of 22 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Multi-domain
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#3,166

Across all tracked assignees

Innovation Score

51.0 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Titan Medical Inc. hold?
Titan Medical Inc. holds 119 US granted patents filed between 2015 and 2025, spanning 22 technology areas.
What is Titan Medical Inc.'s Innovation Score?
Titan Medical Inc. has an Innovation Score of 51.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Titan Medical Inc. focus on?
Titan Medical Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 111 patents. The company has filed patents in 22 CPC subclasses total.
Is Titan Medical Inc.'s patent filing rate increasing or decreasing?
Titan Medical Inc.'s recent filing velocity is +296% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Titan Medical Inc.'s patents?
Titan Medical Inc.'s patents average 19.2 claims each. This falls within the standard range, providing solid legal coverage.
How is the Titan Medical Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

A61B technology

Titan Medical Inc.'s primary CPC class — all holders and yearly trends
Top 50 patent holders

See where Titan Medical Inc. ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope